Supernus Pharmaceuticals, Inc.

Patent Owner

Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 54193
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 564
 
 
 
C07D HETEROCYCLIC COMPOUNDS 4143
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 286
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2122
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2150
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1123
 
 
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 157

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0150,816 DRUG FORMULATIONS HAVING REDUCED ABUSE POTENTIALDec 08, 14Jun 04, 15[A61K]
2015/0141,645 METHODS OF PRODUCING MOLINDONE AND ITS SALTSJan 29, 15May 21, 15[C07D]
2015/0126,735 METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOFDec 19, 14May 07, 15[C07D, C07C]
2015/0086,629 STABILIZED FORMULATIONS OF CNS COMPOUNDSApr 25, 14Mar 26, 15[A61K]
2015/0024,055 ENHANCED IMMEDIATE RELEASE FORMULATIONS OF TOPIRAMATEOct 06, 14Jan 22, 15[A61K]
2014/0303,252 OSMOTIC DRUG DELIVERY SYSTEMApr 30, 14Oct 09, 14[A61K]
2014/0187,552 METHOD OF TREATMENT OF AGGRESSIONJul 26, 13Jul 03, 14[A61K]
2014/0135,326 METHOD OF TREATMENT OF AGGRESSIONNov 13, 13May 15, 14[A61K]
2013/0202,661 FORMULATIONS OF VILOXAZINEFeb 07, 13Aug 08, 13[A61K]
2013/0011,483 FORMULATIONS OF MAZINDOLMar 30, 11Jan 10, 13[A61P, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,992,989 Sustained-release formulations of topiramateSep 29, 14Mar 31, 15[A61K]
8,957,206 Methods of producing molindone and its saltsMar 15, 13Feb 17, 15[C07D]
8,906,413 Drug formulations having reduced abuse potentialMay 12, 03Dec 09, 14[A61K]
8,889,191 Sustained-release formulations of topiramateDec 17, 10Nov 18, 14[A61K, B82Y]
8,877,248 Sustained-release formulations of topiramateJul 14, 14Nov 04, 14[A61K]
8,821,930 Modified release preparations containing oxcarbazepine and derivatives thereofDec 11, 13Sep 02, 14[A61K]
8,808,714 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeuticsJan 10, 11Aug 19, 14[A61F, A61K]
8,747,897 Osmotic drug delivery systemApr 27, 06Jun 10, 14[A61K]
8,748,472 Stabilized formulations of CNS compoundsMar 30, 11Jun 10, 14[A61K]
8,709,476 Compositions of quaternary ammonium compounds containing bioavailability enhancersNov 04, 04Apr 29, 14[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0037,745 CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATEABANSep 24, 13Feb 06, 14[A61K]
2012/0302,615 METHOD OF TREATMENT OF CNS DISORDERSABANDec 02, 10Nov 29, 12[A61P, A61K]
2012/0115,871 METHOD OF TREATMENT OF DEPRESSIONABANApr 29, 10May 10, 12[A61P, A61K]
2011/0003,870 METHOD OF TREATMENT OF A NEUROLOGICAL DISORDERABANJun 30, 10Jan 06, 11[A61P, A61K]
2010/0209,489 Formulations of desvenlafaxineABANFeb 02, 10Aug 19, 10[A61P, A61K]
2010/0173,907 Method of treatment of aggressionABANDec 18, 09Jul 08, 10[A61P, A61K]
2010/0069,390 Method of treatment of attention deficit/hyperactivity disorder (ADHD)ABANSep 04, 09Mar 18, 10[A61P, A61K]
2009/0304,794 CONTROLLED RELEASE FORMULATIONS OF PRAMIPEXOLEABANJun 05, 09Dec 10, 09[A61P, A61K]
2009/0022,789 ENHANCED FORMULATIONS OF LAMOTRIGINEABANJul 18, 07Jan 22, 09[A61P, A61K]
2008/0131,501 Enhanced immediate release formulations of topiramateABANDec 04, 07Jun 05, 08[A61P, A61K]
2007/0249,537 ABSORPTION ENHANCING AGENTSABANApr 27, 07Oct 25, 07[A61P, A61K]
2007/0134,315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compoundABANDec 08, 05Jun 14, 07[A61K]
2007/0104,782 Modified release tablet formulations with enhanced mechanical propertiesABANJul 28, 06May 10, 07[A61K]
2006/0210,625 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atomsABANNov 04, 04Sep 21, 06[A61K]
2005/0191,343 Micellar systems useful for delivery of lipophilic or hydrophobic compoundsABANNov 24, 04Sep 01, 05[A61K]
2004/0202,693 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problemABANApr 13, 04Oct 14, 04[A61K]
2004/0167,203 Absorption enhancing agentsABANJan 22, 04Aug 26, 04[A61K]
2004/0062,800 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profilesABANOct 21, 03Apr 01, 04[A61K]
2004/0028,729 Pharmaceutical formulations with improved bioavailabilityABANApr 29, 03Feb 12, 04[A61K]
2004/0005,339 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailabilityABANDec 20, 02Jan 08, 04[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.